Figure 1. Rate of antimicrobial resistance in S. pneumoniae

Slides:

Advertisements

Similar presentations

Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada:

Advertisements

Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.

The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Antibiotics and Vaccines

Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.

Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.

David Marash-Whitman 11/20/13. KPC (Klebsiella pneumoniae carbapenemase) 18 infected patients 6 fatalities complete drug resistance persistent presence.

Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.

Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.

 decimals/cc-7th-fracs-to-decimals/v/converting-fractions-to-decimals-example.

Nosocomial E. coli Urine Isolates 1991 – Nosocomial K. pneumoniae Urine Isolates

Acute Bacterial Otitis Media Summary and Charge to the Committee Renata Albrecht, M.D. Division of Special Pathogen and Immunologic Drug Products ODEIV,

SWEDRES 2004 Figures and Tables. SWEDRES 2004 Table Total use of antobacterial drugs in Sweden DDD/1000/day Data source: The National.

Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Nosocomial E. coli Urine Isolates Nosocomial K. pneumoniae Urine Isolates

HAP and VAP Guidelines Update

Antibiotics: handle with care!

Tuberculosis in the United States

Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.

Antimicrobial Resistance at GLA

Figure 1. Percentage of Penicillin Non-Susceptible S

Toronto Invasive Bacterial Diseases Network

Tuberculosis in the United States

Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.

Toronto Invasive Bacterial Diseases Network

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Antibiotic resistance and serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae from children in Marrakech region (Morocco) Karima.

Tuberculosis in the United States

G. Cornaglia, A. Lönnroth, M. Struelens

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

The State of Pneumococcal Disease Prevention

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre.

Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media Fernando Baquero, Rafael Cantón, Fernando.

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

Pneumococcal conjugate vaccines: overview of a decade from Kuwait

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

D.E. Low Clinical Microbiology and Infection

…monitoring trends in antimicrobial resistance in Canada

Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage Ron Dagan, Drora Fraser, Noga Givon, Pablo.

G. Höffken Clinical Microbiology and Infection

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Percentage of Penicillin Non-Susceptible S

Figure 1. Percentage of Penicillin Non-Susceptible S

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

J. Garau Clinical Microbiology and Infection

Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas.

Community-acquired pneumonia in adults

Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model Karl Ekdahl, Otto Cars Clinical Microbiology.

Clinical Microbiology and Infection

…monitoring trends in antimicrobial resistance in Canada

Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures B. Herer, C. Fuhrman, Z. Gazevic,

Leanne B. Gasink, MD, Neil O. Fishman, MD, Mark G

Scottish One Health Antimicrobial Use and Resistance in 2017 Annual Report

Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents Clinical Microbiology and Infection Volume.

Modification of prescribers’ behavior: the Icelandic approach

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

…monitoring trends in antimicrobial resistance in Canada

Presentation transcript:

Figure 1. Rate of antimicrobial resistance in S. pneumoniae Percentage of non-susceptible isolates Toronto Invasive Bacterial Diseases Network, Oct 2004

Figure 2. Fluoroquinolone-Resistant Pneumococci in Adults =>50 yrs Percentage of non-susceptible isolates Toronto Invasive Bacterial Diseases Network, Oct 2004

Figure 3. Antibiotic resistance in S Figure 3. Antibiotic resistance in S. pneumoniae by history of prior antibiotic use Percentage of non-susceptible isolates Toronto Invasive Bacterial Diseases Network, Oct 2004

Figure 4. Rate of fluoroquinolone resistance in isolates from patients who have and have not had prior therapy with any fluoroquinolone Percentage of non-susceptible isolates Toronto Invasive Bacterial Diseases Network, Oct 2004

Figure 5. Rate of fluoroquinolone resistance in isolates from patients who have and have not had prior therapy with the same fluoroquinolone Percentage of non-susceptible isolates Toronto Invasive Bacterial Diseases Network, Oct 2004